YAP/TAZ-TEAD inhibitor (Hanmi Pharmaceuticals)

N/A

Report date: 2025/03/20 14:41:52
NME

Base Information

Drug NameYAP/TAZ-TEAD inhibitor (Hanmi Pharmaceuticals)
Drug Alias NameTEAD palmitoylation site inhibitor (Hanmi Pharmaceuticals)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTranscriptional coactivator YAP1 inhibitorsTafazzin inhibitorsTranscriptional enhancer factor inhibitors
TargetsTranscriptional enhancer factorTranscriptional coactivator YAP1Tafazzin
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHanmi Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHanmi Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A